US Patent Issued to SHANGHAI ZHIMENG BIOPHARMA on Dec. 9 for "Tetrahydro-1H-benzazepine compound as potassium channel modulator, preparation method and use thereof" (Chinese Inventors)

ALEXANDRIA, Va., Dec. 9 -- United States Patent no. 12,492,170, issued on Dec. 9, was assigned to SHANGHAI ZHIMENG BIOPHARMA INC. (Shanghai).

"Tetrahydro-1H-benzazepine compound as potassium channel modulator, preparation method and use thereof" was invented by Bo Liang (Shanghai), Qiu Jin (Shanghai), Huanming Chen (Shanghai), Zhijun Zhang (Shanghai) and Bo Hua (Shanghai).

According to the abstract* released by the U.S. Patent & Trademark Office: "A tetrahydro-1H-benzazepine compound as a potassium channel modulator, a preparation method, and a medicament containing the compound are provided. Specifically, the compound has the structure shown by formula A, in which the definitions of each group and substituent are described in the descrip...